<DOC>
	<DOCNO>NCT00301119</DOCNO>
	<brief_summary>RATIONALE : Screening test use biomarkers may help doctor find tumor cell early plan effective treatment lung cancer . PURPOSE : This clinical trial study biomarkers screen participant lung cancer .</brief_summary>
	<brief_title>Lung Cancer Biomarkers Screening</brief_title>
	<detailed_description>OBJECTIVES : - Identify validate biomarkers early detection lung cancer individual low- high-risk smoking-related cancer . - Identify preneoplastic cellular change lesion patient . OUTLINE : Participants stratify accord lung cancer risk status ( without increase risk ) . Group 1 ( screen cohort ) : Participants complete questionnaire undergo pulmonary function testing , multidetector chest CT scan , sputum induction , phlebotomy . Group 2 ( rule-out lung cancer ) : Participants complete questionnaire undergo test scan group 1 . Some participant may undergo fiberoptic bronchoscopy base upon CT scan result transbronchial endobronchial biopsy . Some participant may undergo lung resection . Tissue sample collect surgery biopsy . PROJECTED ACCRUAL : A total participant accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Screening Cohort At high lowrisk lung cancer Smoking history â‰¥ 20 pack years* With without workplace exposure asbestos NOTE : * Participants &lt; 20 pack year smoke eligible 50 year age old RuleOut Lung cancer group Referred evaluation suspicious nodule 1 follow diagnosis : Lung cancer Nonmalignant nodule ( control group ) PATIENT CHARACTERISTICS : Not pregnant No prior malignancy except nonmelanoma skin cancer PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>small cell lung cancer</keyword>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>smoker lung cancer screen</keyword>
	<keyword>low dose spiral CT screening</keyword>
</DOC>